US 8883840
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
granted A61KA61K31/407A61P
Quick answer
US patent 8883840 (Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/407, A61P, A61P1/00, A61P1/02